Latest Licensing News

Page 10 of 186
Bayan Mining has finalised the sale of its Bayan Springs North Project to Sun Silver, securing upfront and contingent payments while retaining a 1% royalty to maintain exposure to future exploration success.
Maxwell Dee
Maxwell Dee
26 Aug 2026
Deep Yellow Limited has locked in two pivotal agreements for its Tumas uranium project in Namibia, securing long-term water supply and formalising local ownership with Oponona Investments. These milestones pave the way for construction progress and a Final Investment Decision expected later this year.
Maxwell Dee
Maxwell Dee
26 Aug 2026
Vysarn Limited reported a robust 31.5% increase in revenue to $140 million for FY2026, driven by strong performances across its industrial, advisory, and technology segments. The company is accelerating its national footprint with strategic acquisitions and progressing the Kariyarra Water Scheme.
Victor Sage
Victor Sage
26 Aug 2026
NeuroScientific Biopharmaceuticals posted a $4.69 million loss for FY2026, driven by R&D ramp-up and clinical progress with its StemSmart™ platform, while halting independent development of its glaucoma drug EmtinB to pursue licensing deals.
Ada Torres
Ada Torres
25 Aug 2026
Racura Oncology's FY2026 results reveal a widening loss despite a 22% revenue dip, underpinned by significant scientific progress on its lead drug targeting the elusive MYC gene and a robust $34.3 million cash position.
Ada Torres
Ada Torres
25 Aug 2026
St George Mining has formally begun environmental permitting for its Araxá Project in Brazil, submitting key assessments to Minas Gerais regulators as it moves toward developing a rare earths and niobium mine.
Maxwell Dee
Maxwell Dee
25 Aug 2026
Janison Education Group posted a 3% revenue rise to $48.1 million in FY26, underpinned by international contract expansion and AI innovation, despite margin pressure from onboarding costs.
Victor Sage
Victor Sage
25 Aug 2026
Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals secured European Commission approval for DAYBU (trofinetide) to treat Rett syndrome symptoms in patients aged five and older, marking the first EU-authorised treatment for this condition.
Victor Sage
Victor Sage
25 Aug 2026
NZME delivered a notable turnaround in the first half of 2026, doubling operating profit and cutting net debt by $13.9 million, led by strong audio revenue and digital expansion despite a challenging economic backdrop.
Elise Vega
Elise Vega
25 Aug 2026
Nanoveu’s half-year report reveals a sharp drop in revenue and a widening net loss, offset by key technological milestones including a 16nm AI chip tape-out, drone efficiency gains, and a strategic robotics acquisition.
Sophie Babbage
Sophie Babbage
24 Aug 2026
Resouro Strategic Metals reported a $1.01 million loss for Q1 2026 while advancing its Tiros Rare Earths and Titanium Project with a robust Preliminary Economic Assessment and closed a $2.5 million private placement.
Maxwell Dee
Maxwell Dee
24 Aug 2026
WT Financial Group (ASX: WTL) delivered its sixth consecutive year of growth in FY2026, with net profit before tax up 19% to $6.55 million and a fully franked final dividend declared at 0.75 cents per share. The company also completed a strategic disposal of its B2C subsidiaries, advancing its Hubco investment model.
Claire Turing
Claire Turing
24 Aug 2026

Browse the archive

Full archive